ZONE-SPECIFIC ADRENOCORTICAL CELL LINES
ZONE-SPECIFIC ADRENOCORTICAL CELL LINES
批准号:
3367565
负责人:
KEITH L. PARKER
金额:
$19.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-05-01 至 1996-02-29
关键词:
adrenal hypertension adrenal medulla neoplasm beta galactosidase cell differentiation cell line familial hypertension gene expression genetic promoter element genetically modified animals hormone regulation /control mechanism laboratory rat northern blottings oncogenes reporter genes steroid hormone tissue /cell culture
中文摘要
高血压是一种多因素疾病,肾脏异常,
心血管和内分泌系统都会产生血压
提升 这些系统之间复杂的相互作用阻碍了
努力查明原发性高血压的原因。 无序
在某些临床上,肾上腺类固醇生成明显诱导高血压。
并有助于更复杂的高血压的发病机制
states. 研究类固醇激素生物合成的正常调节
并确定皮质类固醇的具体作用,
高血压,发展肾上腺皮质细胞是有利
保持分化功能的线条。 老鼠是逻辑
这些细胞系的来源,因为它在整个动物中的卓越作用
类固醇激素的生物合成和遗传模型的研究
高血压 SV 40大T抗原(TAg)的转基因靶向具有以下优点:
被其他人用来生产永生化细胞系,
分化功能。 将TAg靶向表达至
转基因大鼠肾上腺皮质将产生永生化细胞
从离散区域导出的线。 三个基因的启动子区
将使用类固醇生成酶:类固醇11 β-羟化酶,
选择性地在内区表达,即醛固酮合成酶,它是
选择性地表达于肾小球外膜,类固醇21
- 羟化酶,其在所有皮质区中表达。 这些启动子
在体内仅在肾上腺皮质细胞中表达,
细胞保持分化的表型。 两种方法将
用于增加获得分化细胞系的机会。
首先,将在转基因大鼠中诱导肾上腺皮质肿瘤,
TAg的靶向表达。 第二,将准备转基因动物
在特定的肾上腺皮质中表达温度敏感性TAg
区界限 单个克隆将来源于肿瘤细胞,
(野生型TAg)或肾上腺皮质细胞的原代培养物(温度-
敏感的TAg)和肾上腺皮质功能的各种参数将被
研究了
肾上腺皮质在高血压新遗传模型中的作用,
Ren-2转基因大鼠也将被研究。小鼠表达
特定肾上腺皮质区的Ren-2将确定重要部位
治疗高血压 其他实验将确定,如果
在特定的皮质区域中大鼠肾素基因的过度表达也
诱发高血压。 这些研究将扩展以前的结果,
小鼠Ren-2基因,从而增加我们对
高血压的遗传模型中的肾素的影响。
英文摘要
Hypertension is a multifactorial disease, and abnormalities in the renal,
cardiovascular, and endocrine systems all produce blood pressure
elevation. The complex interactions of these systems have hindered
efforts to identify the causes of primary hypertension. Disordered
adrenal steroidogenesis clearly induces hypertension in certain clinical
settings and contributes to the pathogenesis of more complex hypertensive
states. To study the normal regulation of steroid hormone biosynthesis
and to define the specific contributions of corticosteroids to
hypertension, it would be advantageous to develop adrenocortical cell
lines that maintain differentiated function. The rat is the logical
source of these cell lines because of its preeminent role in whole-animal
studies of steroid hormone biosynthesis and genetic models of
hypertension. Transgenic targeting of SV40 large T antigen (TAg) has
been used by others to produce immortalized cell lines that retained
differentiated function. Targeted expression of TAg to specific zones of
the adrenal cortex in transgenic rats will generate immortalized cell
lines derived from discrete zones. The promoter regions of three
steroidogenic enzymes will be used: steroid 11 beta-hydroxylase, which is
selectively expressed in the inner zones, aldosterone synthase, which is
selectively expressed in the outer zona glomerulosa, and steroid 21
-hydroxylase, which is expressed in all cortical zones. These promoters
are expressed in vivo only in adrenocortical cells, and they may ensure
that the cells maintain a differentiated phenotype. Two approaches will
be used to increase the chances of obtaining differentiated cell lines.
First, adrenocortical tumors will be induced in transgenic rats by
targeted expression of TAg. Second, transgenic animals will be prepared
that express a temperature-sensitive TAg in specific adrenocortical
zones. Individual clones will be derived from either the tumors
(wild-type TAg) or primary cultures of adrenocortical cells (temperature-
sensitive TAg) and various parameters of adrenocortical function will be
studied.
The role of the adrenal cortex in a novel genetic model of hypertension,
the Ren-2 transgenic rat, will also be investigated. Expression of mouse
Ren-2 in specific adrenocortical zones will identify essential site(s)
for the hypertension. Additional experiments will establish if
over-expression of the rat renin gene in specific cortical zones also
induces hypertension. These studies will extend previous results with
the mouse Ren-2 gene, and will thus increase our understanding of the
effects of renin in this provocative genetic model of hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Steroidogenic Factor 1: Mediator of Gonadal Function
-
批准号:6768076
-
项目类别:
-
资助金额:$31.59万
-
财政年份:2004
-
负责人:KEITH L. PARKER
-
依托单位:
Steroidogenic Factor 1: Mediator of Gonadal Function
-
批准号:7006962
-
项目类别:
-
资助金额:$30.85万
-
财政年份:2004
-
负责人:KEITH L. PARKER
-
依托单位:
Steroidogenic Factor 1: Mediator of Gonadal Function
-
批准号:6871339
-
项目类别:
-
资助金额:$31.59万
-
财政年份:2004
-
负责人:KEITH L. PARKER
-
依托单位:
Steroidogenic Factor 1: Mediator of Gonadal Function
-
批准号:7173001
-
项目类别:
-
资助金额:$29.95万
-
财政年份:2004
-
负责人:KEITH L. PARKER
-
依托单位:
SF1--KEY MEDIATOR OF ENDOCRINE DEVELOPMENT AND FUNCTION
-
批准号:2843567
-
项目类别:
-
资助金额:$32.03万
-
财政年份:1999
-
负责人:KEITH L. PARKER
-
依托单位:
SF-1-Key Mediator of Endocrine Development and Function
-
批准号:7216269
-
项目类别:
-
资助金额:$27.81万
-
财政年份:1999
-
负责人:KEITH L. PARKER
-
依托单位:
SF-1-Key Mediator of Endocrine Development and Function
-
批准号:6629908
-
项目类别:
-
资助金额:$29.33万
-
财政年份:1999
-
负责人:KEITH L. PARKER
-
依托单位:
SF1--KEY MEDIATOR OF ENDOCRINE DEVELOPMENT AND FUNCTION
-
批准号:6381242
-
项目类别:
-
资助金额:$33.31万
-
财政年份:1999
-
负责人:KEITH L. PARKER
-
依托单位:
SF-1-Key Mediator of Endocrine Development and Function
-
批准号:7035758
-
项目类别:
-
资助金额:$28.64万
-
财政年份:1999
-
负责人:KEITH L. PARKER
-
依托单位:
SF-1-Key Mediator of Endocrine Development and Function
-
批准号:6883993
-
项目类别:
-
资助金额:$29.33万
-
财政年份:1999
-
负责人:KEITH L. PARKER
-
依托单位:
SF-1-Key Mediator of Endocrine Development and Function
-
批准号:6702598
-
项目类别:
-
资助金额:$29.33万
-
财政年份:1999
-
负责人:KEITH L. PARKER
-
依托单位:
SF1--KEY MEDIATOR OF ENDOCRINE DEVELOPMENT AND FUNCTION
-
批准号:6177701
-
项目类别:
-
资助金额:$32.48万
-
财政年份:1999
-
负责人:KEITH L. PARKER
-
依托单位:
SF1--KEY MEDIATOR OF ENDOCRINE DEVELOPMENT AND FUNCTION
-
批准号:6517511
-
项目类别:
-
资助金额:$34.17万
-
财政年份:1999
-
负责人:KEITH L. PARKER
-
依托单位:
StAR in Regulated Steroidogenesis
-
批准号:6727331
-
项目类别:
-
资助金额:$31.2万
-
财政年份:1998
-
负责人:KEITH L. PARKER
-
依托单位:
Roles of StAR in Regulated Steroidogenesis
-
批准号:7172901
-
项目类别:
-
资助金额:$29.58万
-
财政年份:1998
-
负责人:KEITH L. PARKER
-
依托单位:
Roles of StAR in Regulated Steroidogenesis
-
批准号:6836005
-
项目类别:
-
资助金额:$31.2万
-
财政年份:1998
-
负责人:KEITH L. PARKER
-
依托单位:
ROLES OF STAR IN REGULATED STEROIDOGENESIS
-
批准号:2603396
-
项目类别:
-
资助金额:$22.89万
-
财政年份:1998
-
负责人:KEITH L. PARKER
-
依托单位:
Roles of StAR in Regulated Steroidogenesis
-
批准号:6990489
-
项目类别:
-
资助金额:$30.47万
-
财政年份:1998
-
负责人:KEITH L. PARKER
-
依托单位:
ROLES OF STAR IN REGULATED STEROIDOGENESIS
-
批准号:6178066
-
项目类别:
-
资助金额:$24.01万
-
财政年份:1998
-
负责人:KEITH L. PARKER
-
依托单位:
ROLES OF STAR IN REGULATED STEROIDOGENESIS
-
批准号:2906227
-
项目类别:
-
资助金额:$23.44万
-
财政年份:1998
-
负责人:KEITH L. PARKER
-
依托单位: